ABAna Rita Barreiros

Ana Rita Barreiros

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ana Rita Barreiros has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Gin S. Malhi

    Academic Department of Psychiatry, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; CADE Clinic and Mood-T, Royal North Shore Hospital, Northern Sydney Local Health District, St. Leonards, Australia

    5 shared publications
  • Mayuresh S. Korgaonkar

    Brain Dynamics Centre, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia

    5 shared publications
  • Anthony Harris

    Brain Dynamics Centre, Westmead Institute for Medical Research, Sydney, Australia; Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Specialty of Psychiatry, Sydney Medical School, The University of Sydney, Sydney, Australia

    4 shared publications
  • Philip Boyce

    Specialty of Psychiatry, Sydney Medical School, The University of Sydney, Sydney, Australia

    4 shared publications
  • Anthony Harris

    Faculty of Medicine and Health, University of Sydney, NSW, Australia

    3 shared publications
  • Kenta Funayama

    Research, Takeda Pharmaceutical Company Ltd., Fujisawa, Japan

    3 shared publications

Latest Publications

  • Open Access

    Role of the rostral anterior cingulate cortex in emotion processing in Treatment Resistant Depression

    by Ana Rita Barreiros, Isabella Breukelaar, Prashanth Mayur, Jagadeesh Andepalli, Yoshiro Tomimatsu, Kenta Funayama, Sheryl Foster, Anthony Harris, Mayuresh Korgaonkar

    The rostral anterior cingulate cortex (rACC) has been identified as a key region in treatment-resistant depression (TRD), potentially influencing the adaptive interplay between the default mode network and other critical neural networks. This study aims to further uncover the role of the rACC in TRD by investigating its differential connectivity during tasks that evoke conscious and non-conscious emotional responses. Thirty-one TRD patients, 35 treatment-sensitive depression (TSD) patients, and 37 healthy controls (HC) underwent 3T fMRI while performing tasks designed to elicit emotional responses to facial expressions under supraliminal and subliminal conditions. Connectivity patterns of the rACC were analyzed using seed-based and region-of-interest (ROI) approaches. During the processing of positive emotions in the subliminal task, TRD patients showed increased rACC connectivity to the cerebellum and middle temporal gyrus, compared to HC and TSD. Furthermore, significant hypoconnectivity between the rACC and hippocampus was found in the TRD, during the supraliminal processing of positive emotions, compared to TSD and HC. Altered neural connectivity to both subliminal and supraliminal processing of positive facial emotion distinguishes TRD from healthy individuals and patients who respond to depression treatments. This observation fits with anhedonia symptoms that persist in TRD and our findings point to altered connectivity between the rACC and regions involved in emotion regulation and contextualisation during non-conscious processing of positive stimuli.


  • Open Access

    fMRI neurofeedback for the modulation of the neural networks associated with depression

    by Ana Rita Barreiros, Isabella B. Breukelaar, Anthony W.F. Harris, Mayuresh S. Korgaonkar


  • Open Access

    Amygdala subregional functional connectivity in Treatment-Resistant Depression

    by Sheryl L. Foster, Ramon Landin-Romero, Sarah Lewis, Ana Rita Barreiros, Sophie Matis, Anthony Harris, Mayuresh S. Korgaonkar

    Background: Treatment resistance impacts almost 50% of depression patients, with amygdala dysfunction being widely implicated. The amygdala is a complex amalgamation of subnuclei with diverse functions but fMRI studies have typically focussed on identifying whole rather than subregional amygdala functional connectivity. This study used high resolution 3T fMRI data to investigate subregional alterations that may differentiate treatment-resistant cohorts from healthy individuals and depressed patients who respond to treatment. Methods: Resting-state fMRI data were obtained in 35 participants diagnosed with Treatment-Resistant Depression (TRD), 38 healthy control participants (HC), and 35 treatment-sensitive participants (TSD). Seed-based functional connectivity analyses of the three main subregions bilaterally (laterobasal, centromedial and superficial), as well as the whole amygdala, were performed and comparisons made between groups. Results: We found c onnectivity differences in the right laterobasal amygdala subregion in TRD compared to both groups. TRD patients displayed hypoconnectivity to the right fusiform gyrus relative to HC whereas hyperconnectivity to the left inferior frontal gyrus relative to TSD was identified. No connectivity differences were found for the whole amygdala or any of the other subregions bilaterally. Limitations: Modest sample size and cross-sectional study design are limitations. A causal relationship between functional connectivity alterations and treatment resistance cannot be established. Conclusion: Altered connectivity of the right laterobasal subregion is a distinguishing feature of TRD. These alterations may underlie severe impairments in emotion processing and social functioning that are characteristic of TRD. These results emphasise the need for further investigation of the functional role of the amygdala subregions in depression.


  • Open Access

    Intra- and Inter-Network connectivity of the default mode network differentiates Treatment-Resistant depression from Treatment-Sensitive depression

    by Ana Rita Barreiros, Isabella A. Breukelaar, Amourie Prentice, Prashanth Mayur, Yoshiro Tomimatsu, Kenta Funayama, Sheryl Foster, Gin S. Malhi, Martijn Arns, Anthony Harris, et al.


  • Open Access

    Abnormal habenula functional connectivity characterizes treatment-resistant depression

    by Ana Rita Barreiros, Isabella Breukelaar, Prashanth Mayur, Jagadeesh Andepalli, Yoshiro Tomimatsu, Kenta Funayama, Sheryl Foster, Philip Boyce, Gin S. Malhi, Anthony Harris, et al.


  • Open Access

    Neurophysiological markers of attention distinguish bipolar disorder and unipolar depression

    by Ana R. Barreiros, Isabella A. Breukelaar, Wenting Chen, May Erlinger, Cassandra Antees, Meredith Medway, Philip Boyce, Philip Hazell, Leanne M. Williams, Gin S. Malhi, et al.


  • Neural Circuits Underlying Treatment-Resistant Depression

    by Ana Rita Barreiros, Cassandra Chakouch, Isabella Breukelaar, Wenting Chen, Sabina Rai, Prashanth Mayur, Philip Boyce, Sheryl Foster, Gin S. Malhi, Anthony Harris, et al.


  • S119. Electrophysiological Differences Between Individuals With Remitted Bipolar Disorder and Major Depression Compared to Healthy Controls

    by Ana Rita Barreiros, Isabella Breuklaar, Cassandra Antees, Philip Boyce, Philip Hazel, Leanne Williams, Gin S. Malhi, Mayuresh Korgaonkar, Anthony Harris

  • Open Access

    Amygdala Modulation During Emotion Regulation Training With fMRI-Based Neurofeedback

    by Ana Rita Barreiros, Inês Almeida, Bárbara Correia Baía, Miguel Castelo-Branco

    Available evidence suggests that individuals can enhance their ability to modulate brain activity in target regions, within the Emotion Regulation network, using fMRI-based neurofeedback. However, there is no systematic review that investigates the effectiveness of this method on amygdala modulation, a core region within this network. The major goal of this study was to systematically review and analyze the effects of real-time fMRI-Neurofeedback concerning the neuromodulation of the amygdala during Emotion Regulation training. A search was performed in PubMed, Science Direct, and Web of Science with the following key terms: ≪(“neurofeedback” or “neuro feedback” or “neuro-feedback”) and (“emotion regulation”) and (fMRI OR “functional magnetic resonance”),≫ and afterwards two additional searches were performed, replacing the term “emotion regulation” for “amygdala” and “neurofeedback” for “feedback.” Of the 531 identified articles, only 19 articles reported results of amygdala modulation during Emotional Regulation training through rtfMRI-NF, using healthy participants or patients, in original research articles. The results, systematically reviewed here, provide evidence for amygdala's modulation during rtfMRI-NF training, although studies' heterogeneity precluded a quantitative meta-analysis—the included studies relied on different outcome measures to infer the success of neurofeedback intervention. Thus, a qualitative analysis was done instead. We identified critical features influencing inference on the quality of the intervention as: the inclusion of a Practice Run, a Transfer Run and a Control Group in the protocol, and to choose adequate Emotion Regulation strategies—in particular, the effective recall of autobiographic memories. Surprisingly, the Regulated vs. Control Condition was lacking in most of the studies, precluding valid inference of amygdala neuromodulation within Session. The best controlled studies nevertheless showed positive effects. The type of stimulus/interface did not seem critical for amygdala modulation. We also identified potential effects of lateralization of amygdala responses following Up- or Down-Regulation, and the impact of fMRI parameters for data acquisition and analysis. Despite qualitative evidence for amygdala modulation during rtfMRI-NF, there are still important limitations in the design of a clear conceptual framework of NF-training research. Future studies should focus on more homogeneous guidelines concerning design, protocol structure and, particularly, harmonized outcome measures to provide quantitative estimates of neuromodulatory effects in the amygdala.